ReikoX: Dont know, he runs Canna A+B
Drucker, who is an endocrinologist, Banting and Best Diabetes Centre-Novo Nordisk Chair in Incretin Biology and professor of medicine in the division of endocrinology at University of Toronto and has a laboratory based in the Lunenfeld Tanenbaum Research Institute at Mount Sinai Hospital in Toronto, said GLP-1s have gone from scientists questioning why anyone would want to use an injectable sulfonylurea to a class of drugs that have numerous benefits, including: reductions in albuminuria, atherosclerosis, body weight, blood pressure, cell death, fibrosis, glucose, gut motility, inflammation, oxidative stress, platelet aggregation, postprandial lipemia and thrombosis
is supported by the National Key R&D Program of China (2022YFA1303000), the National Natural Science Foundation of China (32225025, 32321004, 92254305), the CAS Project for Young Scientists in Basic Research (YSBR-076) and the New Cornerstone Science Foundation through the XPLORER PRIZE
This contrasts with IV drips, which, despite being safe under medical supervision, carry a slight risk of infection or vein irritation
